Showing results (1081-1090 of 1,129) with videos related to

Sort By:
Pageof 113
Plant Disease|July 16, 2019
Performance and Profitability of Fungicides for Managing Soybean White Mold: A 10-Year Summary of Cooperative TrialsJhonatan P Barro, Maurício C Meyer, Claúdia V Godoy, et al.
Pathogens (Basel, Switzerland)|August 6, 2021
Reporter Virus Neutralization Test Evaluation for Dengue and Zika Virus Diagnosis in Flavivirus Endemic AreaJannyce G C Nunes, Bruno T D Nunes, Chao Shan, et al.
Clinical and Experimental Rheumatology|June 23, 2021
Diagnostic and therapeutic care pathway for fibromyalgiaPiercarlo Sarzi-Puttini, Valeria Giorgi, Fabiola Atzeni, et al.
Genomics Data|October 21, 2015
High-quality draft genome sequence of Kocuria marina SO9-6, an actinobacterium isolated from a copper mineDaniel B A Castro, Letícia Bianca Pereira, Marcus Vinícius M E Silva, et al.
Chembiochem : a European Journal of Chemical Biology|June 30, 2026
Contrast Agents for Enhanced Bioimaging: A Comprehensive ReviewPaulo Sérgio Taube, Donald Fernandes, Arthur Abinader Vasconcelos, et al.
European Journal of Medicinal Chemistry|June 19, 2015
Thiosemicarbazones as Aedes aegypti larvicidalJoão Bosco P da Silva, Daniela Maria do A F Navarro, Aluizio G da Silva, et al.
Biomed Research International|April 3, 2015
TRAF1/C5 but not PTPRC variants are potential predictors of rheumatoid arthritis response to anti-tumor necrosis factor therapyHelena Canhão, Ana Maria Rodrigues, Maria José Santos, et al.
Nature Materials|September 8, 2020
ILC1 drive intestinal epithelial and matrix remodellingGeraldine M Jowett, Michael D A Norman, Tracy T L Yu, et al.
JAMA|November 10, 2020
Effect of Vitamin D Supplementation, Omega-3 Fatty Acid Supplementation, or a Strength-Training Exercise Program on Clinical Outcomes in Older Adults: The DO-HEALTH Randomized Clinical TrialHeike A Bischoff-Ferrari, Bruno Vellas, René Rizzoli, et al.
Lancet (London, England)|September 6, 2014
Efficacy, safety, and immunogenicity of the human papillomavirus 16/18 AS04-adjuvanted vaccine in women older than 25 years: 4-year interim follow-up of the phase 3, double-blind, randomised controlled VIVIANE studyS Rachel Skinner, Anne Szarewski, Barbara Romanowski, et al.
Pageof 113